Plasmodium vivax poses a particular challenge to malaria control because it can lie dormant in the liver and cause relapses weeks or months after the initial infection. In Pakistan, one of the ...

Engineered extracellular vesicles incorporating a viral fusogenic protein and bacterial intein enable efficient intracellular delivery of therapeutic proteins and RNA.

The molecular repertoire of helminth excretory/secretory products (ESPs), which includes proteins, peptides, lipids, and RNA-carrying extracellular vesicles (EVs), underscores their potential to ...

Liver Surgery and NHC Key Lab of Transplant Engineering and Immunology, Institutes for Systems Genetics; National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, ...

Hydroxytyrosol produced by engineered Escherichia coli strains activates Nrf2/HO-1 pathway: An in vitro and in vivo study.

This important study investigates the propensity of the intravacuolar pathogen, Leishmania, to scavenge lipids which it utilizes for its accelerated growth within macrophages. The authors present ...

Isolation and Identification of Compounds from Bioactive Extracts of Taraxacum officinale Weber ex F. H. Wigg. (Dandelion) as a Potential Source of Antibacterial Agents.

Founded in May 2001 and continuously supported by Bloomberg Philanthropies, the Johns Hopkins Malaria Research Institute conducts discovery research at the Bloomberg School of Public Health in ...